AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05839093 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intraligamentary Injection Group
Description: An infiltration was performed at the buccal side of the affected tooth with 0.5 mL using a normal syringe and a 27-G needle. Then, an intraligamentary injection was performed with a special pressure injection syringe (Sopira Citoject, Kulzer, Hanau, Germany) and a 30-G needle. The needle was placed alongside the tooth and inserted at a 30 angle relative to the longitudinal axis of the crown with the needle between the teeth and the bone. Then, in the mesiobuccal, distobuccal, mesiolingual and distolingual portions of teeth, 0.18 mL of the solution was injected. Five minutes later, the teeth were isolated and the endodontic procedure was started.
Study NCT05191576 — intervention group
Intervention type: OTHER
Intervention: Children's sleep habits questionnaire (CSHQ)
Description: 1. Children's Sleep Habits Questionnaire is a validated tool to screen sleep behavior in young children's assessment of pediatric sleep problems.~2. DSM-V Level II Sleep Disturbance- Child Report. is retrospective, 8-item self-report used to assess the pure domain of sleep disturbances in children and adolescents age of 11-17 years in the past seven days.Higher scores indicate more severe sleep disorders. High scores on a particular domain might indicate significant and problematic areas for the child that may warrant further assessment.~3. DSM -V Sleep Disturbance -Adult Report. is used to assess the pure domain of sleep disturbances in adults for the past seven days.~   SDQ).is used to screen emotional and behavioral problems in children.~4. SDQ is used to screen emotional and behavioral problems in children.
Study NCT06486259 — intervention group
Intervention type: OTHER
Intervention: Controlled mechanical ventilation
Description: Patients were ventilated under similar tidal volume, respiratory rate, and plateau pressure. PEEP was the adjustment variable to reach a similar plateau pressure
Study NCT04969250 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Moderna mRNA-1273 COVID-19 vaccine
Description: 100 µg intramuscular injection
Study NCT04969250 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pfizer BNT162b2 COVID-19 vaccine
Description: 30 µg intramuscular injection
Study NCT06046573 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Support and information
Description: Emotional and technical support. Information about the long-term effects of cancer.
Study NCT06046573 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral activation
Description: Behavioral activation with existential themes and emphasis on values and relationships.
Study NCT06046573 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Systematic exposure with mindfulness training
Description: Systematic exposure with mindfulness training with a focus on anxiety about health and/or death, body image, and cancer-related trauma.
Study NCT06352398 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: erector spina plan block
Description: erector spina plan block
Study NCT06352398 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Serratus posterior superior intercostal plan block (SPSIPB)
Description: Serratus posterior superior intercostal plan block (SPSIPB)
Study NCT06352398 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.25% bupivacaine
Description: Before the operation, 0.25% bupivacaine 30 ml was administered to both groups.
Study NCT05377333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3457263
Description: Administered SC.
Study NCT05377333 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC.
Study NCT05377333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered SC.
Study NCT05377333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Description: Administered SC.
Study NCT06046573 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Promotion of health behaviors
Description: An overview of self-management techniques in terms of physical exercise, dietary advice, and strategies for improved sleep.
Study NCT04812912 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hormone biomarker analysis
Description: For female patients, hormone biomarker analysis will be performed to measure: anti-Mullerian hormone (AMH), estradiol and FSH in the blood. In male patients, hormone biomarkers of testicular function and spermatogenesis will be monitored: testosterone, inhibin B, steroid hormone binding globulin (SHBG) and FSH. Sperm analysis will also be performed in male patients to monitor changes in sperm count.
Study NCT04812912 — intervention group
Intervention type: BEHAVIORAL
Intervention: QoL Questionnaires
Description: All participants will respond to protocol questionnaires, which will include both validated questionnaires as well as non-validated ones. This design will allow for basic demographic, psychosocial and sexual-health-related data to be obtained.
Study NCT04945395 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AFO and Conventional training
Description: The control group will be fitted with an ankle-foot-orthosis (AFO) according to clinical practice to enhance dorsiflexion of the foot while taking part in conventional rehabilitation interventions during 4 weeks of inpatient rehabilitation including walking and mobility training in the subacute phase after hemiplegic stroke
Study NCT04896489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 20 MG
Description: Participants receive Hydrocortisone 20 MG
Study NCT04896489 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants receive placebo
Study NCT05818735 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electroacupuncture (EA) treatment
Description: The regular acupuncture treatment will be applied at the acupoints including Baihui (GV20), Yintang (GV29), Guanyuan (RN4), Qihai (RN6), bilateral ZuSanli (ST36) and bilateral SanYinjiao (SP6). After needle insertion, rotating or lifting-thrusting manipulation will be applied for 'De qi' sensation. Three pairs of electrodes of the electroacupuncture apparatus will be connected to the needles of GV20 and GV29, and bilateral ST36 and SP6 for 25 minutes, delivering a continuous wave with a frequency of 2-8Hz which is based on the tolerance of each patient. The selection of matching acupuncture points will be determined by the acupuncturist according to the patients' different syndrome patterns.
Study NCT05818735 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: sham acupuncture (SA) treatment
Description: The sham acpunture treatment will be applied at the same acupoints as the EA treatment with the Streitberger placebo needles. When the blunt needle tip of the placebo needles touches the skin, the patient will get a pricking sensation, but there is no real needle inserted into the skin. The electroacupuncture apparatus will be set on the table beside the patients and two pairs of electrodes will be connected to the needles at bilateral ST36 and SP6. Acupuncturists will turn on the apparatus but all indicators will be set to '0'. Participants will be informed when needles are removed after 25 minutes. Acupuncturists will use dry cotton balls to press the skin around the acupoints when withdrawing the needles so that patients can feel the withdrawal of the 'needles'.
Study NCT05818735 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Escitalopram 10mg
Description: Escitalopram will be used as the antidepressants for relieving patients' depressive mood. The dose of the drug will be the minimum clinical starting dose of 10 mg once daily, taken orally in the morning, for a period of 3 months. During the intervention period, patients will be allowed to increase the drug dose (up to 20 mg) according to their mental status. Patients will record the details of the drug dose, duration of dosing,responses and possible side effects on a drug dairy. Pateints will receive 7 tablets of escitalopram from an independent dispencer at a set time each week. They may receive additional dose of escitalopram once again during the week if necessary and it will be recorded by the dispenser.
Study NCT05818735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo drugs are tablets of the same color and size as escitalopram tablets, consisting mainly of starch, and will be tested for safety before being used in the trial. The way the medication is dispensed, the details of how the medication is administered, the dosage, and the record of the drug diary are consistent with the application of the real drugs.
Study NCT04866264 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: eNutrition Optimizer
Description: The eNutrition optimizer is based on the electronic food frequency questionnaire (FFQ) used in the multicentre randomized controlled trail DO-HEALTH \[56\] developed by the CAM. The FFQ is split up in sections of 33 food groups and contains 216 items. It asks the user on the relative frequency of consumption of the different foods showing a picture of the food in the portion size of interest. Within the eNutrition Optimizer, the FFQ will be extended to create an output of the user's adherence to the Mediterranean diet, the MIND diet and the adherence with the current dietary recommendations for micro- and macronutrients provided by the Swiss Society for Nutrition and the DACH-references, compare it to the DO-HEALTH population and give recommendations on how to improve the score.
Study NCT02934373 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: A New Sound Processor
Study NCT05152693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low variety
Description: Meal components are mixed together on the plate
Study NCT05152693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Variety
Description: Meal components are served separately on the plate
Study NCT05152693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Small Portion Size
Description: Small meal portion size
Study NCT05152693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Large Portion Size
Description: Large meal portion size
Study NCT05152693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: With Beverage
Description: Meal served with water
Study NCT06565728 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3 2000 UNT Oral Tablet
Description: To assess the role of vitamin D3, versus sildenafil citrate, versus control group in pregnancies complicated by fetal growth restriction
Study NCT04740112 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Foods with beta-glucan from oats and barley
Description: Breakfast bars made with varying levels of total dietary fiber and beta-glucan, with or without claims on package image
Study NCT04740112 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foods with beta-glucan from oats and barley
Description: Breakfast bars made with varying levels of total dietary fiber and beta-glucan, with or without claims on package image
Study NCT06522230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fascial Stretch Therapy
Description: Fascial Stretch Protocol uses a combination of circumduction, traction, proprioceptive neuromuscular facilitation (PNF) and specific FST maneuvers. Stretch is applied in both active \& passive methods taking into consideration: (1) Oscillatory - slow passive joint oscillations (back and forth movement in a regular rhythm). Small controlled oscillations help with proprioceptors around the joints, acilitates blood flow, gently stretches the ligaments, tendons, nerves, \& muscles and slows the nervous system down; (2) Traction - allows for assessment of the joint capsule movement and to decompress the joint. (3) Movement - designed to enhance the reflexes and are intentionally gentle to maximize benefits; (4) PNF - helps improve flexibility by alternating muscle contractions and relaxations. This stimulates the neuromuscular system, allowing muscles to relax deeper and increase range of motion. (5) Breath - allows the body to increase oxygen consumption to facilitate recovery.
Study NCT05152693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Without Beverage
Description: Meal served without water
Study NCT06436053 — intervention group
Intervention type: DEVICE
Intervention: LBBAP with SyncAV
Description: Acute changes in surface ECG QRS duration resulting from left bundle branch area pacing using various pacing configurations will be evaluated.
Study NCT06513897 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupressure
Description: Acupressure will be applied to the foreheads of the babies in this group starting two minutes before the heel prick. Acupressure application will be finished when heel prick blood collection is finished.
Study NCT06513897 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Father's Lap
Description: Infants in this group will be placed on the father's lap two minutes before heel prick blood collection. They will remain on the father's lap during the heel prick procedure.
Study NCT05870306 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pulmonary vein isolation and targeted radiofrequency ablation
Description: Radiofrequency will be delivered around the left atrial ostia to isolate the veins. Extra radiofrequency ablation will be performed on the targeted areas
Study NCT05870306 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: pulmonary vein isolation
Description: Radiofrequency will be delivered around the left atrial ostia to isolate the veins.
Study NCT05935540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ACP-Family
Description: It consists of two sessions (45-60 mins) to be delivered within one month in a face-to-face format as long as the patient is still in the hospital. The treatment will be continued in the patient's home if he/she is discharged before the two sessions are completed.~The treatment will cover five elements in ACP, namely (1) patients' understanding of their illness, (2) patients' values and beliefs underpinning care preferences, (3) possible health conditions in the future, (4) introducing the idea of AD and its arrangement, and (5) construction of the role of substituted decision maker. A 3-min video on end-of-life treatment options will be shown to help patients and family members to clearly understand the related topic. However, there will be no restriction on the order of the five topics to be discussed during the intervention.
Study NCT06634914 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Moonbrew
Description: A blend of adaptogens with Chamomile, Rose, and Magnesium in a powdered form, designed to be mixed in liquid and consumed 2-3 hours before bed.
Study NCT06634550 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan technique
Description: The participants will receive Mulligan technique (modified SNAGs) (10 rep. / 3 sets with 5 min rest in between) for 30 minutes, 3 sessions / week in addition to lifestyle modification advice for 4 weeks.
Study NCT06634550 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stability exercise
Description: The participants will perform core stability exercises (spinus multifiduse ex, diaphragmatic strengthening ex, frontal plank, pelvic floor ex,) 3 sessions / week for 30 min each session in addition to lifestyle modification advice for 4 weeks
Study NCT06634550 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lifestyle modification advice
Description: The participants will receive lifestyle modification advice only for 4 weeks
Study NCT06634550 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle modification advice
Description: The participants will receive lifestyle modification advice only for 4 weeks
Study NCT06634511 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core stability exercises
Description: Group A: core stability exercise group:15 Patients assigned to this group will undergo a core stability exercises ts.2times per week /8weeksin addition to conventional therapy (Infrared radiation (using BL 220 Infrared lamp, MT03009201 model) for 15 minutes, Transcutaneous Electrical Nerve stimulation (using model DX66053, pain modulation mode) for 10 minutes~Group B:(aerobic exercise group) 15 patients will receive aerobic exercise in the form of treadmill for 30 minutes2 session per week/8 weeks~Group C(conventional group): 15 patients will receive Infrared radiation (using BL 220 Infrared lamp, MT03009201 model) for 15 minutes, Transcutaneous Electrical Nerve stimulation (using model DX66053, pain modulation mode) for 10 minutes, Participants were treated twice weekly
Study NCT06635187 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Speech and swallowing assessment
Description: This is an observational study in which post-stroke patients will undergo a series of assessments tapping oral-motor and speech functions. Both behavioral and instrumental examinations will be used. Their performance will be captured via an artificial intelligence(AI)-powered mobile health application. The relation between the oral/speech-motor movements captured by the app and their performance as measured via instruments/behavioral means will be investigated.
Study NCT06635512 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Stress Ball Application After Transurethral Resection of the Prostate on Patients' Recovery Quality and Hospital Discharge Time
Description: The effect of the stress ball applied after surgery on patients' recovery quality will be evaluated.
Study NCT05348681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RIST4721
Description: RIST4721 tablets, 100 mg are blue, oval, biconvex film-coated tablets
Study NCT05348681 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study NCT06517849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Monetary Incentive for Take-Up of Cognitive Behavioral Therapy
Description: Both treatment arms will be offered a monetary incentive (in form of a retail gift card) for undergoing a certain number of CBT sessions.
Study NCT04829409 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Paravertebral block
Description: Patients receive ultrasound-guided paravertebral block
Study NCT04829409 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ESP block
Description: Patients receive ultrasound-guided erector spinae plane (ESP) block
Study NCT04829409 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MTP block
Description: Patients receive ultrasound-guided mid-point transverse process to pleura (MTP) block
Study NCT05201820 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Description: Cryoanalgesia will be applied during surgery on 6 intercostal nerves each side
Study NCT06568198 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real tACS
Description: α-tACS at a frequency of alpha band at S1
Study NCT06568198 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham tACS
Description: Sham tACS with no stimulation applied
Study NCT05599204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: schroth exercise
Description: the patients will receive the Schroth three-dimensional exercise. patient first assumes a posture in the cervico-cranial and shoulder girdle and the thoracic region is held in the correct posture. The patient inspires air into the concave side and during the exhalation phase isometric and isotonic muscle tensing occur. While the patient is breathing, the therapist should observe the posture and movement of the thoracic cage and diaphragm. Basic posture correction in sitting and walking and Sensorimotor training by the ball will be applied
Study NCT05599204 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: postural correction exercise
Description: the patients will receive postural correction exercises, stretches, and exercises to the pectoralis major, elevator scapulae, upper trapezius, serratus anterior, rhomboids, and deep neck flexors. The stretches included sitting chair stretches, Brugger's, wall angels, and doorway stretches. The exercises included push up- plus, head-neck-retraction, and Kibler squeeze
Study NCT05599204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: postural correction exercise
Description: the patients will receive postural correction exercises, stretches, and exercises to the pectoralis major, elevator scapulae, upper trapezius, serratus anterior, rhomboids, and deep neck flexors. The stretches included sitting chair stretches, Brugger's, wall angels, and doorway stretches. The exercises included push up- plus, head-neck-retraction, and Kibler squeeze
Study NCT06521671 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dynaloc implant
Description: Internal fixation with Dynaloc implant
Study NCT06521671 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cannulated cancellous screws
Description: Internal fixation with two or three cannulated cancellous screws
Study NCT04937751 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: biomarkers
Description: galactomannan, betaDglucan, resistance markers
Study NCT06191705 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: QuickDASH
Description: Participants will be administered Urdu version of QuickDASH to collect data regarding Disabilities of Arm, Shoulder \& Hand twice with a time interval of 72 hours to determine validity and reliability.
Study NCT05209282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Based Action Observation
Description: Individuals in this group will receive video-based action observation training in addition to the conventional physiotherapy program.
Study NCT05209282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Live Action Observation
Description: Individuals in this group will receive live action observation training in addition to the conventional physiotherapy program.
Study NCT05209282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy program
Description: Individuals in this group will only receive a conventional physiotherapy program.